EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase II)Klinische Studie (Phase III)Open Access · CC BY-NC-ND 4.0

An integrated Phase II/III randomized study comparing durvalumab and tremelimumab ± Hepatic ArteriaL infusion chemotherapy with GEMOX in hepatocellular Carcinoma with high tumor burdEn – ALICE (PRODIGE89 – UCGI44 – ALICE)

Octave Letissier, Xavier Adhoute, Boris Campillo-Gimenez, Mohamed Bouattour, Jean-Marie Peron, Amina Larbi, François Ghiringhelli, Yann Touchefeu, Anaïs Vallet-Pichard, Laurent Mineur, Valérie Boige, Antonio Saviano und 12 weitere

Digestive and Liver Disease · 2026

DOI: 10.1016/j.dld.2026.08.030 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Digestive and Liver Disease, 2026. Verfasst von Octave Letissier und 23 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, Centre Eugène Marquis, Rennes, France. Hauptthemen laut MEDLINE: Liver Neoplasms, Antibodies, Monoclonal, Humanized, Antineoplastic Combined Chemotherapy Protocols, Deoxycytidine. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: French National Cancer Institute, AstraZeneca PLC, Unicancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsDeoxycytidineCarcinoma, HepatocellularAntibodies, MonoclonalHumansInfusions, Intra-ArterialGemcitabineHepatic ArteryTumor BurdenOxaliplatinFranceOrganoplatinum Compounds

Stichwörter der Autor:innen

Hepatic arterial infusion chemotherapyHepatocellular carcinomaImmunotherapyPortal vein tumour thrombosis

Substanzen

Antibodies, Monoclonal, HumanizedDeoxycytidineAntibodies, MonoclonaltremelimumabdurvalumabGemcitabineOxaliplatinOrganoplatinum Compounds

Autor:innen und Institutionen

  • Medical Oncology, Centre Eugène Marquis, Rennes, France.
  • Gastroenterology, Saint Joseph Hospital, Marseille, France.
  • Biostatistics, Eugène Marquis Center, Rennes, France.
  • Digestive Hepato-oncology, Beaujon Hospital, Clichy, France.
  • Hepatology, Rangueil Hospital, Toulouse, France.
  • Gastroenterology, Poitiers Hospital, Poitiers, France.

Förderung

  • French National Cancer Institute
  • AstraZeneca PLC
  • Unicancer

Zitieren

APA

Letissier, O., Adhoute, X., Campillo-Gimenez, B., Bouattour, M., Peron, J. M., Larbi, A., Ghiringhelli, F., Touchefeu, Y., Vallet-Pichard, A., Mineur, L., Boige, V., Saviano, A., Blanc, J. F., Amaddeo, G., Rosmorduc, O., Allaire, M., Decaens, T., Fiore, F. D., Khac, E. N., …, & Edeline, J. (2026). An integrated Phase II/III randomized study comparing durvalumab and tremelimumab ± Hepatic ArteriaL infusion chemotherapy with GEMOX in hepatocellular Carcinoma with high tumor burdEn – ALICE (PRODIGE89 – UCGI44 – ALICE). Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.08.030

Vancouver

Letissier O, Adhoute X, Campillo-Gimenez B, Bouattour M, Peron JM, Larbi A, et al. An integrated Phase II/III randomized study comparing durvalumab and tremelimumab ± Hepatic ArteriaL infusion chemotherapy with GEMOX in hepatocellular Carcinoma with high tumor burdEn – ALICE (PRODIGE89 – UCGI44 – ALICE). Digestive and Liver Disease. 2026. doi:10.1016/j.dld.2026.08.030

BibTeX
@article{Letissier2026,
  author = {Letissier, Octave and Adhoute, Xavier and Campillo-Gimenez, Boris and Bouattour, Mohamed and Peron, Jean-Marie and Larbi, Amina and Ghiringhelli, François and Touchefeu, Yann and Vallet-Pichard, Anaïs and Mineur, Laurent and Boige, Valérie and Saviano, Antonio and Blanc, Jean-Frédéric and Amaddeo, Giuliana and Rosmorduc, Olivier and Allaire, Manon and Decaens, Thomas and Fiore, Frédéric Di and Khac, Eric Nguyen and Monard, Laure and Pezzella, Veronica and Hariz, Aïcha Ben and Guiu, Boris and Edeline, Julien},
  title = {An integrated Phase II/III randomized study comparing durvalumab and tremelimumab ± Hepatic ArteriaL infusion chemotherapy with GEMOX in hepatocellular Carcinoma with high tumor burdEn – ALICE (PRODIGE89 – UCGI44 – ALICE)},
  journal = {Digestive and Liver Disease},
  year = {2026},
  doi = {10.1016/j.dld.2026.08.030}
}
Kostenlos starten →